Eligo Bioscience Revenue and Competitors

Paris, France

Location

N/A

Total Funding

Fintech

Industry

Estimated Revenue & Valuation

  • Eligo Bioscience's estimated annual revenue is currently $6.9M per year.(i)
  • Eligo Bioscience's estimated revenue per employee is $117,000

Employee Data

  • Eligo Bioscience has 59 Employees.(i)
  • Eligo Bioscience grew their employee count by 9% last year.

Eligo Bioscience's People

NameTitleEmail/Phone
1
VP TechnologyReveal Email/Phone
2
Head Finance & AdministrationReveal Email/Phone
3
Junior CMC ManagerReveal Email/Phone
4
Clinical Development LeadReveal Email/Phone
5
Associate ScientistReveal Email/Phone
6
Associate scientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$181.5M997-2%N/AN/A
#2
$110.8M682-6%N/AN/A
#3
$38.5M2696%N/AN/A
#4
$90.5M557-2%N/AN/A
#5
$21.5M150-18%N/AN/A
#6
$27.5M192-37%N/AN/A
#7
$113.8M68919%$311.8MN/A
#8
$37M25923%N/AN/A
#9
$51.5M31714%N/AN/A
#10
$258.4M142035%N/AN/A
Add Company

What Is Eligo Bioscience?

Eligo Bioscience is a biotechology company that develops a new class of biotherapeutics for microbiome precision-editing.

keywords:N/A

N/A

Total Funding

59

Number of Employees

$6.9M

Revenue (est)

9%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Eligo Bioscience News

2022-04-17 - Biotech Tries Manipulating the Skin Microbiome

... is favored by Parisbased biotech company Eligo Bioscience, ... Eligo's platform targets bacterial genes specifically associated with...

2022-04-17 - Biotech Tries Manipulating the Skin Microbiome

... is favored by Parisbased biotech company Eligo Bioscience, ... Eligo's platform targets bacterial genes specifically associated with...

2022-04-13 - Acne Treatment Market Size [2022-2028] worth USD 12.97 Billion | exhibiting a CAGR of 4.8%

January 2021: GlaxoSmithKline plc announced that it entered into an agreement with Eligo BioScience with an aim to advance Eligobiotics for...

2022-04-13 - Acne Treatment Market Size [2022-2028] worth USD 12.97 Billion | exhibiting a CAGR of 4.8%

January 2021: GlaxoSmithKline plc announced that it entered into an agreement with Eligo BioScience with an aim to advance Eligobiotics for...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$13M590%N/A
#2
$11.2M5928%N/A
#3
$8.5M59-33%N/A
#4
$7.4M59-2%$16.1M
#5
$7.2M590%$7.3M